{
    "code": "02025095",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025095",
    "time": "2022-05-06 06:08:53",
    "許可證字號": "衛署藥輸字第025095號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/09\/23",
    "發證\/登錄日期": "98\/09\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202509502",
    "中文品名": "博脈舒錠 16 毫克",
    "英文品名": "Blopress Tablets 16 mg",
    "適應症": "本態性高血壓。治療左心室射出分率≦ 40%之心臟衰竭病患，作為血管加壓素轉化酶抑制劑(ACE-inhibitors)的輔助療法，或使用於無法耐受血管加壓素轉化酶抑制劑(ACE-inhibitors)的病人，以減少心臟血管死亡率或心衰竭導致之住院。",
    "劑型": "110錠劑",
    "包裝": "2-1000 錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CANDESARTAN CILEXETIL",
    "限制項目": "02輸　入",
    "申請商名稱": "620118P360  台灣賽特瑞恩有限公司",
    "申請商地址": "臺北市信義區松仁路97號3樓之1",
    "主製造廠": [
        {
            "": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝及分裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005710",
            "成分名稱": "CANDESARTAN CILEXETIL",
            "含量描述": "",
            "含量": "16.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淺粉紅色",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "PDF_A_for Blopress 16mg Foil _ 91239261.Rev1 _ (1100621)-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=002&Type=10"
        },
        {
            "title": "Blopress 16mg 外觀-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PDF_B_for_Insert_Blopress_16mg_91239222.rev1_20210727-110-11-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=003&Type=9"
        },
        {
            "title": "03_中文仿單_Blopress 16mg Leaflet rev2-104-12-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=001&Type=9"
        },
        {
            "title": "PDF_A_for_Box_Blopress_16mg_91239232.rev1_20210617-111-01-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=005&Type=8"
        },
        {
            "title": "Blopress 16mg 外盒-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025095&Seq=004&Type=8"
        }
    ]
}